Azul SA (AZUL) Stock Fundamental Analysis

NYSE:AZUL • US05501U1060

0.5 USD
+0.01 (+2.33%)
At close: May 27, 2025
0.49 USD
-0.01 (-2%)
Pre-Market: 5/28/2025, 8:00:23 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AZUL. AZUL was compared to 22 industry peers in the Passenger Airlines industry. AZUL has a medium profitability rating, but doesn't score so well on its financial health evaluation. AZUL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year AZUL has reported negative net income.
  • AZUL had a positive operating cash flow in the past year.
  • AZUL had negative earnings in each of the past 5 years.
  • AZUL had a positive operating cash flow in 4 of the past 5 years.
AZUL Yearly Net Income VS EBIT VS OCF VS FCFAZUL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B

1.2 Ratios

  • The Return On Assets of AZUL (-24.97%) is worse than 69.57% of its industry peers.
  • AZUL's Return On Invested Capital of 36.38% is amongst the best of the industry. AZUL outperforms 100.00% of its industry peers.
  • AZUL had an Average Return On Invested Capital over the past 3 years of 24.48%. This is above the industry average of 20.70%.
  • The last Return On Invested Capital (36.38%) for AZUL is above the 3 year average (24.48%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -24.97%
ROE N/A
ROIC 36.38%
ROA(3y)-16.76%
ROA(5y)-28.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)24.48%
ROIC(5y)N/A
AZUL Yearly ROA, ROE, ROICAZUL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

  • The Operating Margin of AZUL (19.40%) is better than 95.65% of its industry peers.
  • In the last couple of years the Operating Margin of AZUL has grown nicely.
  • AZUL has a better Gross Margin (56.60%) than 60.87% of its industry peers.
  • In the last couple of years the Gross Margin of AZUL has remained more or less at the same level.
Industry RankSector Rank
OM 19.4%
PM (TTM) N/A
GM 56.6%
OM growth 3YN/A
OM growth 5Y2.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y0.8%
AZUL Yearly Profit, Operating, Gross MarginsAZUL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so AZUL is creating value.
  • The number of shares outstanding for AZUL remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for AZUL has been increased compared to 5 years ago.
  • The debt/assets ratio for AZUL is higher compared to a year ago.
AZUL Yearly Shares OutstandingAZUL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AZUL Yearly Total Debt VS Total AssetsAZUL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • AZUL has an Altman-Z score of -1.07. This is a bad value and indicates that AZUL is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of AZUL (-1.07) is worse than 73.91% of its industry peers.
  • The Debt to FCF ratio of AZUL is 26.68, which is on the high side as it means it would take AZUL, 26.68 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of AZUL (26.68) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 26.68
Altman-Z -1.07
ROIC/WACC6.93
WACC5.25%
AZUL Yearly LT Debt VS Equity VS FCFAZUL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B -20B -30B

2.3 Liquidity

  • AZUL has a Current Ratio of 0.35. This is a bad value and indicates that AZUL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AZUL has a Current ratio of 0.35. This is in the lower half of the industry: AZUL underperforms 78.26% of its industry peers.
  • A Quick Ratio of 0.29 indicates that AZUL may have some problems paying its short term obligations.
  • AZUL's Quick ratio of 0.29 is on the low side compared to the rest of the industry. AZUL is outperformed by 86.96% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.29
AZUL Yearly Current Assets VS Current LiabilitesAZUL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

5

3. Growth

3.1 Past

  • AZUL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.22%.
  • Looking at the last year, AZUL shows a small growth in Revenue. The Revenue has grown by 7.93% in the last year.
  • Measured over the past years, AZUL shows a quite strong growth in Revenue. The Revenue has been growing by 11.28% on average per year.
EPS 1Y (TTM)-46.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-286.35%
Revenue 1Y (TTM)7.93%
Revenue growth 3Y25.09%
Revenue growth 5Y11.28%
Sales Q2Q%-2.44%

3.2 Future

  • The Earnings Per Share is expected to grow by 30.17% on average over the next years. This is a very strong growth
  • AZUL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.43% yearly.
EPS Next Y76.26%
EPS Next 2Y41.52%
EPS Next 3Y30.17%
EPS Next 5YN/A
Revenue Next Year17.51%
Revenue Next 2Y13.22%
Revenue Next 3Y11.43%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AZUL Yearly Revenue VS EstimatesAZUL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
AZUL Yearly EPS VS EstimatesAZUL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6 -8

3

4. Valuation

4.1 Price/Earnings Ratio

  • AZUL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • AZUL is valuated quite expensively with a Price/Forward Earnings ratio of 91.45.
  • AZUL's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AZUL is more expensive than 60.87% of the companies in the same industry.
  • AZUL is valuated expensively when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 91.45
AZUL Price Earnings VS Forward Price EarningsAZUL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AZUL is on the same level as its industry peers.
  • 100.00% of the companies in the same industry are more expensive than AZUL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.64
EV/EBITDA 5.08
AZUL Per share dataAZUL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as AZUL's earnings are expected to grow with 30.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.52%
EPS Next 3Y30.17%

0

5. Dividend

5.1 Amount

  • No dividends for AZUL!.
Industry RankSector Rank
Dividend Yield N/A

Azul SA

NYSE:AZUL (5/27/2025, 8:04:00 PM)

Premarket: 0.49 -0.01 (-2%)

0.5

+0.01 (+2.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)05-14
Earnings (Next)08-07
Inst Owners5.25%
Inst Owner Change-87.11%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap154.03M
Revenue(TTM)20.24B
Net Income(TTM)-6.38B
Analysts47.5
Price Target1.68 (236%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-914.43%
Min EPS beat(2)-1853.43%
Max EPS beat(2)24.56%
EPS beat(4)1
Avg EPS beat(4)-490.46%
Min EPS beat(4)-1853.43%
Max EPS beat(4)24.56%
EPS beat(8)1
Avg EPS beat(8)-354.03%
EPS beat(12)1
Avg EPS beat(12)-252.9%
EPS beat(16)3
Avg EPS beat(16)-185.84%
Revenue beat(2)0
Avg Revenue beat(2)-82.44%
Min Revenue beat(2)-82.5%
Max Revenue beat(2)-82.39%
Revenue beat(4)0
Avg Revenue beat(4)-82.91%
Min Revenue beat(4)-84.21%
Max Revenue beat(4)-82.39%
Revenue beat(8)0
Avg Revenue beat(8)-82.73%
Revenue beat(12)0
Avg Revenue beat(12)-64.15%
Revenue beat(16)2
Avg Revenue beat(16)-48.7%
PT rev (1m)-54.35%
PT rev (3m)-58.3%
EPS NQ rev (1m)-24.77%
EPS NQ rev (3m)-293.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-218.58%
Revenue NQ rev (1m)-2.45%
Revenue NQ rev (3m)-2.38%
Revenue NY rev (1m)1.25%
Revenue NY rev (3m)1.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 91.45
P/S 0.04
P/FCF 0.64
P/OCF 0.34
P/B N/A
P/tB N/A
EV/EBITDA 5.08
EPS(TTM)-3.63
EYN/A
EPS(NY)0.01
Fwd EY1.09%
FCF(TTM)0.79
FCFY157.07%
OCF(TTM)1.48
OCFY296.25%
SpS11.82
BVpS-16.61
TBVpS-17.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.97%
ROE N/A
ROCE 46.05%
ROIC 36.38%
ROICexc 44.79%
ROICexgc 57.89%
OM 19.4%
PM (TTM) N/A
GM 56.6%
FCFM 6.65%
ROA(3y)-16.76%
ROA(5y)-28.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)24.48%
ROIC(5y)N/A
ROICexc(3y)33.92%
ROICexc(5y)N/A
ROICexgc(3y)57.91%
ROICexgc(5y)N/A
ROCE(3y)30.98%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y55.25%
ROICexc growth 3YN/A
ROICexc growth 5Y41.91%
OM growth 3YN/A
OM growth 5Y2.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y0.8%
F-Score4
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 26.68
Debt/EBITDA 4.64
Cap/Depr 43.11%
Cap/Sales 5.89%
Interest Coverage 1.67
Cash Conversion 37.91%
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.29
Altman-Z -1.07
F-Score4
WACC5.25%
ROIC/WACC6.93
Cap/Depr(3y)56%
Cap/Depr(5y)48.67%
Cap/Sales(3y)7.33%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-286.35%
EPS Next Y76.26%
EPS Next 2Y41.52%
EPS Next 3Y30.17%
EPS Next 5YN/A
Revenue 1Y (TTM)7.93%
Revenue growth 3Y25.09%
Revenue growth 5Y11.28%
Sales Q2Q%-2.44%
Revenue Next Year17.51%
Revenue Next 2Y13.22%
Revenue Next 3Y11.43%
Revenue Next 5YN/A
EBIT growth 1Y123.92%
EBIT growth 3YN/A
EBIT growth 5Y14.61%
EBIT Next Year109.01%
EBIT Next 3Y34.3%
EBIT Next 5YN/A
FCF growth 1Y-44.24%
FCF growth 3YN/A
FCF growth 5Y4.57%
OCF growth 1Y-31.77%
OCF growth 3YN/A
OCF growth 5Y1.44%

Azul SA / AZUL FAQ

What is the fundamental rating for AZUL stock?

ChartMill assigns a fundamental rating of 3 / 10 to AZUL.


Can you provide the valuation status for Azul SA?

ChartMill assigns a valuation rating of 4 / 10 to Azul SA (AZUL). This can be considered as Fairly Valued.


How profitable is Azul SA (AZUL) stock?

Azul SA (AZUL) has a profitability rating of 5 / 10.


What is the financial health of Azul SA (AZUL) stock?

The financial health rating of Azul SA (AZUL) is 1 / 10.